Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study

被引：4

作者：

Blanco, A. Calles ^{[1
]}

Mendivil, A. F. Navarro ^{[2
,3
,4
]}

de Speville, B. Doger ^{[5
]}

Colome, E. Alvarez ^{[3
,6
]}

Luken, M. J. De Miguel ^{[7
]}

Alvarez, R. M. ^{[1
]}

Garcia, V. Moreno ^{[8
]}

Ramon, J. ^{[9
]}

Valles, M. Arregui ^{[10
]}

de la Fuente, E. Corral ^{[11
]}

Alcala, D. ^{[12
]}

Fernandez, M. ^{[13
]}

Morato, J. Rodriguez ^{[12
]}

Calvo, E.

Sanchez, R. Palmero ^{[14
]}

Jove, M. ^{[14
]}

Felip, E. ^{[3
,15
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Med Oncol Dept, Madrid, Spain

[2] Vall Hebron Hosp Univ, Dept Med Oncol, Barcelona, Spain

[3] Vall Hebron Inst Oncol VHIO, Barcelona, Spain

[4] MEDSIR Med Sci Innovat Res, Barcelona, Spain

[5] Hosp Univ Fdn Jimenez Diaz, Start Madrid Phase 1 Unit, Madrid, Spain

[6] Vall Hebron Hosp Univ, Med Oncol Dept, Barcelona, Spain

[7] Hosp Madrid Norte Sanchinarro, Ctr Integral Oncol Clara Campal, START Madrid CIOCC, Madrid, Spain

[8] Hosp Univ Fdn Jimenez Diaz, START Madrid FJD Early Phase Clin Trials Unit, Madrid, Spain

[9] Hosp Madrid Norte Sanchinarro, Ctr Integral Oncol Clara Campal, Med Oncol, START Madrid CIOCC, Madrid, Spain

[10] Hosp Gen Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain

[11] Hosp Madrid Norte Sanchinarro, Dept Oncol, Ctr Integral Oncol Clara Campal, START Madrid CIOCC, Madrid, Spain

[12] MEDSIR Med Sci Innovat Res, Sci Dept, Barcelona, Spain

[13] MEDSIR Med Sci Innovat Res, Trial Dept, Barcelona, Spain

[14] Hosp Duran Reynals, Med Oncol, ICO Inst Catala Oncol, Lhospitalet De Llobregat, Spain

[15] Vall Hebron Univ Hosp, Med Oncol Serv, Lung Canc Unit, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1220

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1989MO

引用

页码：S1060 / S1061

页数：2